Daré Bioscience (DARE) EGM 2026 summary

Opening remarks and agenda

• Special meeting opened at 9:00 A.M. Pacific Time; Sabrina Martucci Johnson chaired, and Cynthia Skoglund of American Election Services served as inspector of election.

• Quorum confirmed; at least one-third of outstanding shares were represented. As of the September 30, 2026 record date, 19,669,083 shares were outstanding and entitled to vote.

• Notice and proxy materials were mailed or made available online on or about October 6, 2026.

Specific resolutions to be voted on

• Proposal 1 sought approval under NASDAQ rules for potential future issuance of common shares upon exercise of outstanding warrants; the board recommended approval.

• Proposal 2 sought authority to adjourn if necessary or advisable to solicit additional proxies for Proposal 1 if votes were insufficient; the board recommended approval.

Overview of voting outcomes

• Preliminary results showed stockholders approved both the potential future warrant-related share issuance and the conditional adjournment proposal.

• Preliminary results reflected votes received by 11:59 p.m. Eastern Time on November 9, 2026; later votes were to be included in the final report, with final results to be reported in an SEC Form 8-K.

• Polls closed at 9:04 A.M. and the meeting adjourned at 9:05 A.M. Pacific Time on November 10, 2026.